• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchRubius Therapeutics
    Picture of Rubius Therapeutics logo

    RUBY — Rubius Therapeutics News Story

    $0.060.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    • Market Cap
      $5.16m
    • Enterprise Value
      -$9.71m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • RUBY Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    RUBY Dividends
    All News

    NASDAQ RESUMED AT 09:44 AM

    Picture of Rubius Therapeutics logoRubius Therapeutics
    11/04/2022 14:44
    NASDAQ RESUMED  RUBY.O  AT 09:44 AM
    

    Recent news on Rubius Therapeutics

    See all news
    • U.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital

      06/03/2023 12:30
    • Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023

      03/03/2023 21:34
    • Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company

      22/02/2023 11:55
    • Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview

      21/02/2023 15:18
    • U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft

      07/02/2023 12:25

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.